pilot
studi
gain
permiss
collabor
institut
studi
patient
wait
area
emerg
depart
busi
pediatr
hospit
busi
public
primari
care
clinic
privat
primari
care
clinic
studi
approv
obtain
central
institut
review
board
cirb
ref
follow
advic
host
medic
staff
medic
facil
select
sampl
locat
patient
congreg
would
dens
prolong
often
involv
triag
area
consult
wait
area
pharmaci
wait
area
ran
type
aerosol
sampler
busi
patient
activ
period
morn
afternoon
session
day
week
week
follow
previou
publish
method
use
skc
biosampl
modifi
liquid
imping
biolit
air
sampl
pump
set
calibr
flow
rate
lmin
biosampl
collect
vessel
prefil
ml
steril
viru
collect
medium
phosphatebuff
salin
pb
wv
bovin
serum
albumin
bsa
fraction
v
place
height
meter
floor
biosampl
run
minut
achiev
total
sampl
air
volum
liter
two
portabl
airchek
touch
person
air
sampler
skc
inc
eighti
four
pa
concomitantli
run
biosampl
separ
area
use
preload
polytetrafluoroethylen
ptfe
teflon
filter
cassett
skc
inc
filter
prewet
isopropanol
reduc
hydrophob
use
filter
cassett
holder
set
posit
height
floor
pump
set
flow
rate
lmin
minut
allow
approxim
liter
total
air
collect
sampl
sampl
period
complet
filter
remov
cassett
swab
flock
swab
prewet
steril
viru
collect
medium
pb
wv
bsa
fraction
v
swab
person
sampler
extrud
one
steril
viru
collect
medium
kept
ice
prior
transport
back
laboratori
hobo
data
logger
onset
comput
corp
bourn
use
collect
air
temperatur
rel
humid
data
sampl
site
devic
set
take
read
interv
bioaerosol
sampl
period
bioaerosol
sampl
transport
wet
ice
dukenu
laboratori
one
health
end
sampl
day
process
laboratori
sampl
concentr
ultrafiltr
use
amicon
filter
unit
merck
darmstadt
germani
aliquot
store
molecular
test
viru
isol
could
conduct
viral
ribonucl
acid
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
inc
valencia
ca
assess
realtim
reversetranscript
polymeras
chain
reaction
qrtpcr
use
superscript
iii
platinum
onestep
rtpcr
system
platinum
taq
dna
polymeras
thermo
fisher
scientif
inc
waltham
world
health
organ
primer
probe
influenza
publish
primer
probe
sequenc
influenza
b
detect
influenza
influenza
bposit
specimen
concentr
posit
sampl
inocul
mdck
cell
dulbecco
modifi
eagl
medium
dmem
contain
uml
penicillin
streptomycin
wv
bsa
mm
hepe
buffer
tpcktrypsin
incub
day
daili
check
cytopath
effect
cpe
made
extract
viral
rna
test
coronaviru
rtpcr
use
superscript
iii
onestep
rtpcr
system
platinum
taq
dna
polymeras
thermo
fisher
scientif
inc
pancoronaviru
univers
primer
target
polymeras
gene
viral
deoxyribonucl
acid
dna
extract
use
qiaamp
dna
blood
mini
kit
qiagen
inc
test
realtim
pcr
qpcr
adenoviru
molecular
assay
use
quantinova
probe
pcr
kit
qiagen
inc
adenovirusposit
specimen
subtyp
use
gelbas
screen
pcr
target
hexon
gene
posit
pcr
band
purifi
use
qiaquick
pcr
purif
kit
qiagen
inc
submit
local
sequenc
compani
aitbiotech
pte
ltd
singapor
sanger
sequenc
adenovirusposit
sampl
concentr
posit
sampl
inocul
cell
dmem
vv
fetal
bovin
serum
incub
day
daili
check
made
cpe
sampl
period
total
biosampl
ptfe
filterbas
cassett
air
sampl
collect
tabl
overal
specimen
indic
evid
least
respiratori
pathogen
tabl
posit
influenza
viru
posit
influenza
b
viru
posit
adenoviru
one
adenovirusposit
specimen
success
studi
partial
hexon
sequenc
found
human
adenoviru
type
base
top
blastn
hit
http
blastncbinlmnihgov
partial
hexon
sequenc
adenovirusposit
specimen
similar
nucleotid
ident
human
adenoviru
isol
access
none
sampl
posit
coronaviru
public
hospit
yield
posit
specimen
among
sampl
collect
posit
influenza
viru
posit
influenza
b
viru
posit
adenoviru
public
primari
care
clinic
yield
posit
adenoviru
specimen
privat
primari
care
clinic
yield
influenza
bposit
adenovirusposit
specimen
none
specimen
cultur
mdck
cell
observ
amplifi
viabl
viru
among
adenovirusposit
specimen
yield
hexon
gene
band
sequenc
identifi
adenoviru
type
viabl
viru
observ
specimen
cultur
cell
among
sampl
collect
use
biosampl
posit
adenoviru
person
sampler
demonstr
higher
rate
molecular
detect
influenza
aposit
influenza
bposit
adenovirusposit
specimen
identifi
sampl
period
air
temperatur
rang
rel
humid
rh
rang
tabl
although
posit
sampl
spars
statist
signific
differ
mean
air
temperatur
mean
rh
group
sampl
testposit
testneg
viru
influenza
viru
influenza
b
viru
adenoviru
although
studi
individu
patient
swab
specimen
consid
gold
standard
clinic
respiratori
viru
detect
character
sever
recent
public
demonstr
aerosol
sampl
may
also
play
import
role
understand
viral
transmiss
number
field
set
aerosol
studi
clearli
document
presenc
influenza
virus
swine
poultri
farm
addit
studi
document
valu
aerosol
sampl
variou
human
set
aerosol
sampl
data
impli
close
humanhuman
contact
may
necessari
transmiss
report
blacher
et
al
found
air
sampl
collect
us
hospit
emerg
depart
posit
influenza
viru
report
wan
et
al
document
molecular
evid
adenoviru
mycoplasma
pneumonia
aerosol
sampl
obtain
taiwanes
pediatr
hospit
report
bischoff
et
al
found
molecular
evid
influenza
within
meter
hospit
patient
suggest
healthcar
profession
might
expos
infecti
smallparticl
aerosol
report
grayson
lednicki
coleman
similarli
found
molecular
evid
respiratori
virus
medic
apart
school
set
sampl
contain
viabl
viru
aerosol
sampl
number
advantag
anim
husbandri
use
explain
transmiss
barn
farm
human
set
aerosol
sampl
involv
minim
intrus
patient
flow
disrupt
clinic
care
direct
patient
contact
requir
inform
consent
contrast
individu
patient
studi
singl
aerosol
specimen
collect
minut
hour
repres
lowcost
way
studi
multipl
patient
goal
inform
healthcar
offici
novel
respiratori
viru
enter
becom
establish
healthcar
set
approach
could
particularli
use
set
larg
number
peopl
congreg
transit
modern
exampl
novel
respiratori
viru
introduct
includ
novel
zoonot
influenza
virus
middl
east
respiratori
syndrom
viru
aerosol
sampl
alreadi
demonstr
detect
novel
influenza
virus
live
anim
market
china
unit
state
gener
find
biolog
understand
found
higher
preval
posit
sampl
public
health
hospit
arguabl
patient
acut
ill
patient
symptom
longer
patient
wait
time
also
observ
higher
respiratori
viru
detect
rate
use
person
sampler
possibl
increas
rate
due
longer
run
period
specimen
combin
result
higher
concentr
target
nucleic
acid
final
find
higher
preval
adenoviru
compar
virus
test
could
explain
rel
environment
stabil
adenovirus
doublestrand
dna
virus
compar
influenza
virus
coronavirus
rna
virus
pilot
studi
limit
could
link
specif
aerosol
result
individu
patient
ill
patient
densiti
popul
studi
like
focu
futur
research
howev
site
report
patient
respiratori
ill
sign
symptom
sampl
period
suggest
sick
accompani
asymptomat
shedder
might
sourc
aerosol
viru
site
viru
emerg
depart
patient
like
manifest
acut
respiratori
enter
diseas
studi
also
limit
strong
cultureposit
evid
viabl
viru
posit
specimen
furthermor
although
focu
studi
uncertain
viabl
viru
present
high
enough
titer
could
caus
humantohuman
infect
howev
number
anim
husbandri
human
medicin
set
detect
molecular
evid
pathogen
strongli
correl
viabl
viru
animaltoanim
humantohuman
animaltohuman
respiratori
transmiss
summari
conduct
pilot
bioaerosol
sampl
studi
medic
facil
singapor
goal
screen
influenza
b
virus
adenovirus
coronavirus
among
wait
patient
period
total
bioaerosol
sampl
collect
site
find
molecular
evid
influenza
viru
influenza
b
viru
adenoviru
collect
sampl
evid
control
sampl
suggest
least
patient
shed
viru
aerosol
respiratori
droplet
aerosol
sampl
noninvas
rel
low
cost
respect
manpow
laboratori
assay
one
see
role
sampl
surveil
respiratori
pathogen
clinic
set
